A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)

Hutchinson, Peter JEdlmann, EllieHanrahan, John GBulters, DiederikZolnourian, ArdalanHolton, PatrickSuttner, NigelAgyemang, KevinThomson, SimonAnderson, Ian AAl-Tamimi, YahiaHenderson, DuncanWhitfield, PeterGherle, MonicaBrennan, Paul MAllison, AnnabelThelin, Eric PTarantino, SilviaPantaleo, BeatriceCaldwell, KarenDavis-Wilkie, CarolMee, HarryWarburton, Elizabeth ABarton, GarryChari, AswinMarcus, Hani JPyne, SarahKing, Andrew TBelli, AntonioMyint, Phyo KWilkinson, IanSantarius, ThomasTurner, CaroleBond, SimonKolias, Angelos GBritish Neurosurgical Trainee Research Collaborative and Dex-CSDH Trial Collaborators2024-03-222024-03-222024-03-01Hutchinson, P J, Edlmann, E, Hanrahan, J G, Bulters, D, Zolnourian, A, Holton, P, Suttner, N, Agyemang, K, Thomson, S, Anderson, I A, Al-Tamimi, Y, Henderson, D, Whitfield, P, Gherle, M, Brennan, P M, Allison, A, Thelin, E P, Tarantino, S, Pantaleo, B, Caldwell, K, Davis-Wilkie, C, Mee, H, Warburton, E A, Barton, G, Chari, A, Marcus, H J, Pyne, S, King, A T, Belli, A, Myint, P K, Wilkinson, I, Santarius, T, Turner, C, Bond, S, Kolias, A G & British Neurosurgical Trainee Research Collaborative and Dex-CSDH Trial Collaborators 2024, 'A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)', Health Technology Assessment, vol. 28, no. 12, pp. 1-122. https://doi.org/10.3310/XWZN48321366-5278ORCID: /0000-0003-3852-6158/work/163198771https://hdl.handle.net/2164/23096Funding This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 13/15/02) and is published in full in Health Technology Assessment; Vol. 28, No. 12. See the NIHR Funding and Awards website for further award information.1224269010engSDG 3 - Good Health and Well-beingAdultHumansAgedHematoma, Subdural, Chronic/drug therapyHospitalizationCost-Benefit AnalysisDouble-Blind MethodDexamethasone/therapeutic useR MedicineRA randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)Journal article10.3310/XWZN48322812